PRELUDE CAPITAL MANAGEMENT, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$11,361,000
+1462.7%
133,613
+551.0%
0.55%
+1272.5%
Q2 2020$727,000
+299.5%
20,523
+167.2%
0.04%
+233.3%
Q2 2018$182,000
+1554.5%
7,680
+997.1%
0.01%
+1100.0%
Q4 2017$11,000
+175.0%
700
+168.2%
0.00%
Q3 2017$4,0002610.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders